The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Clinical proteomics: translating benchside promise into bedside reality
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holland, J. H. (1992) · The MIT Press eBooks · doi:10.7551/mitpress/1090.001.0001 · Cited by 47,002
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-organized formation of topologically correct feature maps
Kohonen, T. (1982) · Biological Cybernetics · doi:10.1007/bf00337288 · Cited by 9,529
Kohonen, T. (1990) · Proceedings of the IEEE · doi:10.1109/5.58325 · Cited by 8,414
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,752
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999) · Nature Biotechnology · doi:10.1038/13690 · Cited by 4,683
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Self-citationPattern Recognition Principles
(2009) · Classification Methods for Remotely Sensed Data, Second Edition · doi:10.1201/9781420090741.ch2 · Cited by 3,188
Self-organized formation of topographically correct feature maps
Kohonen, T. (1982) · Biological Cybernetics · Cited by 2,995
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
Self-citationProtein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Self-citationA Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
The current state of two-dimensional electrophoresis with immobilized pH gradients
Görg, A., Obermaier, C., Boguth, G., Harder, A., Scheibe, B., Wildgruber, R., & Weiss, W. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000401)21:6<1037::aid-elps1037>3.0.co;2-v · Cited by 1,515
A network of protein–protein interactions in yeast
Schwikowski, B., Uetz, P., & Fields, S. (2000) · Nature Biotechnology · doi:10.1038/82360 · Cited by 1,363
Stoeckli, M., Chaurand, P., Hallahan, D. E., & Caprioli, R. M. (2001) · Nature Medicine · doi:10.1038/86573 · Cited by 1,172
Pattern Recognition Principles
Kavzoglu, T., Tso, B., & Mather, P. M. (2024) · Classification Methods for Remotely Sensed Data · doi:10.1201/9781003439172-2 · Cited by 1,053
Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin III, E. F., & Liotta, L. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204265 · Cited by 956
Self-citationPrinciples and Practice of Gynecologic Oncology
Hoskins, W. J., Pérez, C. A., & Young, R. C. (1992) · Cited by 945
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Köchli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63075-1 · Cited by 566
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
Moasser, M. M., Basso, A., Averbuch, S. D., & Rosen, N. X. (2001) · PubMed · Cited by 509
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Kim, J.-H. (2002) · JAMA · doi:10.1001/jama.287.13.1671 · Cited by 480
Molecular profiling of human cancer
Liotta, L., & Petricoin, E. (2000) · Nature Reviews Genetics · doi:10.1038/35049567 · Cited by 446
Self-citationPonder, B. A. J. (2001) · Nature · doi:10.1038/35077207 · Cited by 446
The role of mitogen-activated protein (MAP) kinase in breast cancer
Santen, R. J., Song, R. X., McPherson, R., Kumar, R., Adam, L., Jeng, M.-H., & Yue, W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00189-3 · Cited by 406
Washburn, M. P., Ulaszek, R., Deciu, C., Schieltz, D. M., & Yates, J. R. (2002) · Analytical Chemistry · doi:10.1021/ac015704l · Cited by 390
Zhou, G., Li, H., DeCamp, D., Chen, S., Shu, H., Gong, Y., Flaig, M., Gillespie, J. W., Hu, N., Taylor, P. R., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m100015-mcp200 · Cited by 388
Self-citationQuantitative proteome analysis by solid-phase isotope tagging and mass spectrometry
Zhou, H., Ranish, J. A., Watts, J. D., & Aebersold, R. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-512 · Cited by 384
Cuello, M. A., Ettenberg, S. A., Clark, A. S., Keane, M., Posner, R. H., Nau, M. M., Dennis, P. A., & Lipkowitz, S. (2001) · PubMed · Cited by 370
Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays
Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J., & Schreiber, S. L. (2002) · Nature · doi:10.1038/416653a · Cited by 367
Sreekumar, A., Nyati, M. K., Varambally, S., Barrette, T. R., Ghosh, D., Lawrence, T. S., & Chinnaiyan, A. M. (2001) · PubMed · Cited by 328
Tyrosine kinase inhibitors: From rational design to clinical trials
Traxler, P., Bold, G., Buchdunger, E., Caravatti, G., Furet, P., Manley, P., O'Reilly, T., Wood, J., & Zimmermann, J. (2001) · Medicinal Research Reviews · doi:10.1002/med.1022 · Cited by 324
Development of anticancer drugs targeting the MAP kinase pathway
Sebolt-Leopold, J. S. (2000) · Oncogene · doi:10.1038/sj.onc.1204083 · Cited by 320
Thiesing, J. T., Ohno-Jones, S., Kolibaba, K. S., & Druker, B. J. (2000) · Blood · doi:10.1182/blood.v96.9.3195 · Cited by 309
Rosty, C., Christa, L., Kuzdzal, S. A., Baldwin, W. M., ZAHURAK, M. L., Carnot, F., Chan, D. W., Canto, M. I., Lillemoe, K. D., Cameron, J. L., et al. (2002) · PubMed · Cited by 292
Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y., Liotta, L. A., Kohn, E. C., & Petricoin, E. F. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<76::aid-prot76>3.0.co;2-o · Cited by 290
Self-citationNormanno, N., Campiglio, M., De Luca, A., Somenzi, G., Maiello, M., Ciardiello, F., Gianni, L., Salomon, D. S., & Menard, S. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf020 · Cited by 273
Ball, G., Mian, S., Holding, F., Allibone, R. O., Lowe, J., Ali, S., Li, G., McCardle, S., Ellis, I. O., Creaser, C., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.3.395 · Cited by 260
Receptor tyrosine kinases as targets for anticancer drugs
Zwick, E., Bange, J., & Ullrich, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02217-1 · Cited by 252
Cancer gene therapy: hard lessons and new courses
Vile, R. G., Russell, S. J., & Lemoine, N. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301084 · Cited by 231
Clinical Proteomics: Personalized Molecular Medicine
Liotta, L. A., Kohn, E. C., & Petricoin, E. F. (2001) · JAMA · doi:10.1001/jama.286.18.2211 · Cited by 213
Self-citationKaptain, S., Tan, L. K., & Chen, B. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200109000-00001 · Cited by 208
Cohen, L. S., Escobar, P. F., Scharm, C., Glimco, B., & Fishman, D. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6253 · Cited by 203
New approaches to proteomic analysis of breast cancer
Wulfkuhle, J. D., McLean, K. C., Paweletz, C. P., Sgroi, D. C., Trock, B. J., Steeg, P. S., & Petricoin III, E. F. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1205::aid-prot1205>3.0.co;2-x · Cited by 198
An approach to proteomic analysis of human tumors
Emmert‐Buck, M. R., Gillespie, J. W., Paweletz, C. P., Ornstein, D. K., Basrur, V., Appella, E., Wang, Q. H., Huang, J. L., Hu, N., Taylor, P. R., et al. (2000) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(200003)27:3<158::aid-mc2>3.0.co;2-2 · Cited by 187
Self-citationTrastuzumab: hopes and realities
Leyland-Jones, B. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00676-9 · Cited by 169
Shen, Y., Tolić, N., Zhao, R., Paša-Tolić, L., Li, L., Berger, S. J., Harkewicz, R., Anderson, G. A., Belov, M. E., & Smith, R. D. (2001) · Analytical Chemistry · doi:10.1021/ac001393n · Cited by 169
Proteomic approaches to biomarker discovery in prostate and bladder cancers
Adam, B.-L., Vlahou, A., Semmes, O. J., & Wright, Jr. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1264::aid-prot1264>3.0.co;2-r · Cited by 162
Xiao, Z., Adam, B.-L., Cazares, L. H., Clements, M. A., Davis, J. W., Schellhammer, P. F., Dalmasso, E. A., & Wright, G. L. (2001) · PubMed · Cited by 161
Protein Modules and Signaling Networks
Pawson, T. J. (2000) · Biochemical Society Transactions · doi:10.1042/bst028a127c · Cited by 157
Automatic Identification of Proteins with a MALDI-Quadrupole Ion Trap Mass Spectrometer
Krutchinsky, A. N., Kalkum, M., & Chait, B. T. (2001) · Analytical Chemistry · doi:10.1021/ac010682o · Cited by 144
Recent developments in ovarian cancer screening
Menon, U., & Jacobs, I. J. (2000) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200002000-00007 · Cited by 121
High-throughput protein arrays: prospects for molecular diagnostics
Walter, G., Büssow, K., Lueking, A., & Glökler, J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02352-3 · Cited by 95
Two-Dimensional Electrophoresis: The State of the Art and Future Directions
Herbert, B. R., Sanchez, J., & Bini, L. (1997) · Principles and practice · doi:10.1007/978-3-662-03493-4_2 · Cited by 75
Neural Network Assessment of Perioperative Cardiac Risk in Vascular Surgery Patients
Lapuerta, P., L'Italien, G. J., Paul, S. D., Hendel, R. C., Leppo, J. A., Fleisher, L. A., Cohen, M. C., Eagle, K. A., & Giugliano, R. P. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800114 · Cited by 48
Proteomics comes to the surface
MacBeath, G. (2001) · Nature Biotechnology · doi:10.1038/nbt0901-828 · Cited by 39
From the analysis of protein complexes to proteome-wide linkage maps
Legrain, P., Jestin, J., & Schächter, V. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00117-8 · Cited by 30
Pharmacogenomics of cytochrome P450 and other enzymes involved in biotransformation of xenobiotics
Guengerich, F. P. (2000) · Drug Development Research · doi:10.1002/(sici)1098-2299(200001)49:1<34::aid-ddr6>3.0.co;2-w · Cited by 30
Myocardial SPET: artificial neural networks describe extent and severity of perfusion defects
Lindahl, Palmer, & Edenbrandt (1999) · Clinical Physiology · doi:10.1046/j.1365-2281.1999.00203.x · Cited by 25
Recent advances in immunotherapy and monoclonal antibody treatment of cancer
Cheng, J. D., Rieger, P. T., von Mehren, M., et al. (2000) · Seminars in Oncology Nursing · doi:10.1053/sonu.2000.19775 · Cited by 24
Cell Surface Receptor-Targeted Therapy of Acute Myeloid Leukemia: A Review
Frankel, A. E., Sievers, E. L., & Scheinberg, D. A. (2000) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2000.15.459 · Cited by 20
Cited by
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Ardito, F., Giuliani, M., Perrone, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,336
Tyers, M., & Mann, M. (2003) · Nature · doi:10.1038/nature01510 · Cited by 1,006
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Metadata
- Authors
- Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-09
- Volume
- 1
- Issue
- 9
- Pages
- 683-695
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2007477730
- Cited by
- 550
- References
- 70
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.